newsfilter
← Latest News
ClinicalTrials.gov·

Hutrukin Safety PK Study - NCT05098080

Number of subjects with treatment related adverse events assessed according to CTCAE v5.0 of one single intravenous dose of HutrukinTM in healthy subjects at each dose level., Maximum plasma concentration of test article, Plasma concentration at various time points including terminal concentration, (and 2 more...)